96 participants
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2025-11-07
- Completion:
- 2032-03-31
Conditions
- BRAF V600 Mutation
- Low-grade Glioma
- Low Grade Glioma of Brain
- Recurrent Low Grade Glioma
Interventions
- DRUG
- PROCEDURE
No Results Yet